Purpose/objective In 1988, the World Health Organisation (WHO) adopted a resolution calling for eradication of poliomyelitis. In Algeria, the Acute Flaccid Paralysis (AFP) surveillance is a Key strategy for polio eradication
The objective of the national program for poliomyelitis eradication is to keep Algeria as a zone free of Polio and to obtain the WHO certificate. In the present work, we describe the epidemiological and clinical characteristics of AFP: age, gender, autonomic disorders, albuminocytologic dissociation of CSF, artificial ventilation, and mortality.
Materials and methods Prospective analysis of all cases of AFP from September 1994 to June 2013. Since 1997, we began systematically sending: Written statements of AFP on special forms to the Algerian Health Ministry and stools culture for the Polio virus to Algerian’s Pasteur Institute.
AFP was diagnosed clinically through historical and clinical examination. The underlying cause of AFP was investigated by appropriate laboratory tests, such as serum electrolytes, cerebrospinal fluid analysis, nervous conduction study and stools culture for Polio virus.
Results We report 198 cases of AFP. No case of poliomyelitis has been diagnosed. Mechanical ventilation was necessary in more than 30% of cases. Since 2008, use of intravenous immunoglobulin (IV IG) seems to improve the mortality of AFP. 8% (n = 198) vs. 4% (n = 47). All deaths are related to the existence of severe neuro-vegetative disorders.
The last case of poliomyelitis reported, in Algeria, was in ILLIZI (extreme south east) in 1996.
Conclusions Eradication of Poliomyelitis is a priority of public health in Algeria.